ArticleEpidemiology and health2025

Palivizumab coverage rates among moderate-to-late preterm infants in Korea: a nationwide cross-sectional study.

Seungyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.